Skip to main content
Premium Trial:

Request an Annual Quote

BioCommerce Week s Index to the Diversified Molecular Biology Tools Companies: Sep 30, 2004


BCW Index Takes its First Dip, Falls 8 Percent

After three weeks of gains, the BioCommerce Week Index of Diversified Molecular Biology Tool Companies finished down this week, finishing at $31.25 Tuesday, down 3 percent from last week’s $32.19 close.

The fall is in step with broader market measures. The Dow, the S&P 500, and Nasdaq — as well as the Nasdaq biotech — all finished down, between 1 and 2 percent lower than last week.

Of the 15 companies in the BCW Index, 12 saw their share prices fall during the week. Agilent led this group, falling to $21.29 from $23.32, an 8 percent drop, while shares of Molecular Devices, Waters, PerkinElmer, and Invitrogen fell more than 5 percent during a week when many of the BCW Index company executives were in New York to present at the annual UBS Global Life Sciences Conference.

Beckman Coulter and Applied Biosystems recorded fractions-of-a-percentage gains while Harvard Bio ended even at $4.45.

Agilent’sdrop comes after making gains of 14 percent over the previous weeks since the Index was first published on Sept. 8.

PerkinElmer, even with a 5.38-percent dip this week, still is above its index-opening price of $18.71, while Applied Bio dips below its index opening price of $18.81.

After gaining nearly 20 percent from the start of the index, Invitrogen stands at $55.38, after starting at $48.87.

The index is a weekly compilation of stock prices of a select group of public molecular biology tools companies with multiple platform technologies, and business units with executives dedicated to integrated biology efforts, or with investments in this emerging field.

— Mo Krochmal ([email protected])

File Attachments
The Scan

International Team Proposes Checklist for Returning Genomic Research Results

Researchers in the European Journal of Human Genetics present a checklist to guide the return of genomic research results to study participants.

Study Presents New Insights Into How Cancer Cells Overcome Telomere Shortening

Researchers report in Nucleic Acids Research that ATRX-deficient cancer cells have increased activity of the alternative lengthening of telomeres pathway.

Researchers Link Telomere Length With Alzheimer's Disease

Within UK Biobank participants, longer leukocyte telomere length is associated with a reduced risk of dementia, according to a new study in PLOS One.

Nucleotide Base Detected on Near-Earth Asteroid

Among other intriguing compounds, researchers find the nucleotide uracil, a component of RNA sequences, in samples collected from the near-Earth asteroid Ryugu, as they report in Nature Communications.